Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -42.57% | 13.80% | |||
| Depreciation & Amortization | -12.50% | -38.46% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -43.41% | -12.67% | |||
| Operating Income | 43.41% | 12.67% | |||
| Income Before Tax | 18.05% | 93.33% | |||
| Income Tax Expenses | -- | 100.00% | |||
| Earnings from Continuing Operations | 18.15% | 93.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -75.00% | -66.67% | |||
| Net Income | 17.87% | 93.35% | |||
| EBIT | 43.41% | 12.67% | |||
| EBITDA | 43.50% | 12.57% | |||
| EPS Basic | 19.94% | 93.35% | |||
| Normalized Basic EPS | 19.67% | -173.18% | |||
| EPS Diluted | 20.01% | 93.35% | |||
| Normalized Diluted EPS | 19.67% | -173.18% | |||
| Average Basic Shares Outstanding | 2.57% | 0.10% | |||
| Average Diluted Shares Outstanding | 2.57% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
